Having been awarded best start-up at the 2012 Medilink West Midlands Healthcare Business Awards in December, the list of acalades for Serascience could continue to grow following the recent announcement that the company has now been shortlisted for the Medilink UK Awards.
Some of the world’s most pioneering technologies will be recognised at the prestigious awards ceremony, taking place at the ExCel Centre, London, on March 13. The Medilink UK Healthcare Business Awards, this year supported by the NIHR Devices for Dignity Healthcare Technology Co-operative, is an annual event that celebrates cutting edge technologies, outstanding business achievements and international success across the UK’s Life Sciences sector.
Serascience Limited, is a specialist cancer diagnostic company and the technology is based around monoclonal antibodies used for diagnosis and management of myeloma and related immune cell disorders. This was developed by the clinical immunology group of Professor Mark Drayson in the school of Immunity and Infection.
Related News: